Pete A Williams
Overview
Explore the profile of Pete A Williams including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
1829
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Golpour N, Brautaset R, Hui F, Nilsson M, Svensson J, Williams P, et al.
BMJ Open Ophthalmol
. 2025 Mar;
10(1).
PMID: 40086804
Background: Glaucoma, a leading cause of irreversible blindness worldwide, is characterised by retinal ganglion cell degeneration. Increasing evidence points to metabolic dysfunction, particularly mitochondrial dysfunction, as a contributing factor to...
2.
Bell K, Chrysostomou V, Karlsson M, Jones B, Williams P, Crowston J
Neurobiol Aging
. 2025 Mar;
150:69-79.
PMID: 40073716
Increasing age and elevated intraocular pressure (IOP) are the two major risk factors for glaucoma, the most common cause of irreversible blindness worldwide. Accumulating evidence is pointing to metabolic failure...
3.
4.
Rombaut A, Brautaset R, Williams P, Tribble J
Mol Brain
. 2024 Nov;
17(1):84.
PMID: 39574161
Neuroinflammation is a significant contributor to the pathology of glaucoma. Targeting key-mediators in this process is a realistic option to slow disease progression. Galectin-3 is a β-galactoside binding lectin that...
5.
Hedstrom J, Nilsson M, Engvall M, Williams P, Venkataraman A
Invest Ophthalmol Vis Sci
. 2024 Oct;
65(12):4.
PMID: 39365263
Purpose: To evaluate the correlation between the macular ganglion cell complex (GCC) thickness measured with manually corrected segmentation and visual function in individuals with chronic Leber hereditary optic neuropathy (LHON)....
6.
Stalhammar G, Hagstrom A, Ermedahl Conradi M, Williams P
Surv Ophthalmol
. 2024 Sep;
70(1):38-46.
PMID: 39343315
The prognostic implications of delaying treatment for primary uveal melanoma remain debated. We evaluate the impact of choroidal nevi and melanoma doubling times on metastatic death incidence and compare this...
7.
Tribble J, Joe M, Varricchio C, Otmani A, Canovai A, Habchi B, et al.
Nat Commun
. 2024 Sep;
15(1):8143.
PMID: 39289370
No abstract available.
8.
Cimaglia G, Tribble J, Votruba M, Williams P, Morgan J
Acta Neuropathol Commun
. 2024 Aug;
12(1):137.
PMID: 39180087
A compromised capacity to maintain NAD pools is recognized as a key underlying pathophysiological feature of neurodegenerative diseases. NAD acts as a substrate in major cell functions including mitochondrial homeostasis,...
9.
Tribble J, Joe M, Varricchio C, Otmani A, Canovai A, Habchi B, et al.
Nat Commun
. 2024 Jul;
15(1):6256.
PMID: 39048544
Maintenance of NAD pools is critical for neuronal survival. The capacity to maintain NAD pools declines in neurodegenerative disease. We identify that low NMNAT2, the critical neuronal NAD producing enzyme,...
10.
Rombaut A, Brautaset R, Williams P, Tribble J
Front Ophthalmol (Lausanne)
. 2024 Jul;
3:1290465.
PMID: 38983068
Glaucoma is the leading cause of irreversible blindness. Current treatment options are limited and often only slow disease progression. Metabolic dysfunction has recently been recognized as a key early and...